Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study

A Alcaraz; R González-López; J Morote; C de la Piedra; C Meseguer; E Esteban; M Climent; B González-Gragera; J-L álvarez-Ossorio; I Chirivella; B Mellado; P-C Lara; F Vázquez; J-A Contreras; J Carles; A Murias; V Calderero; J Comet-Batlle; A González-del Alba; L León-Mateos; A Ma?as; J Segarra; A Lassa; C González-Enguita; M-J Méndez; P Samper; M Unda; I Mahillo-Fernández; J Bellmunt

首页> 外文期刊>British Journal of Cancer >Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study

【24h】

Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study

机译：唑来膦酸治疗后肾细胞和膀胱癌伴骨转移的患者骨转换和临床结局的生化指标：TUGAMO研究

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background:Levels of bone turnover markers (BTM) might be correlated with outcome in terms of skeletal-related events (SRE), disease progression, and death in patients with bladder cancer (BC) and renal cell carcinoma (RCC) with bone metastases (BM). We try to evaluate this possible correlation in patients who receive treatment with zoledronic acid (ZOL).

机译：背景：骨转移相关指标（BRE）的水平可能与骨骼相关事件（SRE），疾病进展和患有骨转移的肾癌（RCC）患者的死亡相关（ BM）。我们试图评估接受唑来膦酸（ZOL）治疗的患者的这种可能的相关性。

著录项

来源
《British Journal of Cancer》 |2013年第1期|共10页
作者
A Alcaraz; R González-López; J Morote; C de la Piedra; C Meseguer; E Esteban; M Climent; B González-Gragera; J-L álvarez-Ossorio; I Chirivella; B Mellado; P-C Lara; F Vázquez; J-A Contreras; J Carles; A Murias; V Calderero; J Comet-Batlle; A González-del Alba; L León-Mateos; A Ma?as; J Segarra; A Lassa; C González-Enguita; M-J Méndez; P Samper; M Unda; I Mahillo-Fernández; J Bellmunt;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study [J] . C de la Piedra, A Alcaraz, J Bellmunt, British Journal of Cancer . 2013,第12期

机译：唑来膦酸治疗后骨转移的前列腺癌患者的骨转换指标可作为预测死亡风险，疾病进展和骨骼相关事件的指标：TUGAMO研究
2. Bone turnover markers as predictors of mortality risk in prostate cancer patients with bone metastases following treatment with zoledronic acid. [J] . Jung K, Miller K, Wirth M, European urology . 2011,第4期

机译：骨转换标志物是唑来膦酸治疗后有骨转移的前列腺癌患者死亡风险的预测指标。
3. Effects of intravenous zoledronic acid and oral ibandronate on early changes in markers of bone turnover in patients with bone metastases from non-small cell lung cancer [J] . FranciniF., PascucciA., BargagliG., International journal of clinical oncology . 2011,第3期

机译：静脉注射唑来膦酸和口服伊班膦酸对非小细胞肺癌骨转移患者骨转换标志物早期变化的影响
4. IL-12 is a Useful Marker to Predict Clinical Outcome in Radiotherapy: Down-Regulation of IL-12 Increases Treatment Failure in Locally Advanced Hepatocellular Carcinoma [C] . En-Jung Lee, Yan-Gun Suh, Seojin Lee, International Molecular Medicine Tri-Conference. . 2015

机译：IL-12是一种有用的标记，可预测放疗中的临床结果：IL-12的下调增加了局部晚期肝细胞癌的治疗失败
5. The changes in bone health and biochemical markers of bone turnover in eumenorrheic females with an increase in weight-bearing training volume. [D] . Kawaguchi, Jeffrey Keith. 2003

机译：随着负重训练量的增加，雌性漏尿女性的骨骼健康和骨骼更新的生化标志物的变化。
6. Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study [O] . A Alcaraz, R González-López, J Morote, 2013

机译：唑来膦酸治疗后肾细胞和膀胱癌伴骨转移的患者骨转换和临床结局的生化指标：TUGAMO研究
7. Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study [O] . Alcaraz, A., González-López, Raquel, Morote, J., 2013

机译：用唑来膦酸治疗肾细胞和膀胱癌骨转移患者骨转换和临床转归的生化指标：TUGamO研究

Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study

摘要

著录项

相似文献

相关主题

期刊订阅